Familial hypercholesterolaemia

which include DNA testing, can confirm a diagnosis. Once an accurate diagnosis has been made, people with FH can receive appropriate treatment, and cascade testing can be started to identify affected family members. Quality measures The following measures can be used to assess the quality of care or service provision specified in the statement. They are examples of how the statement can be measured, and can be adapted and used flexibly. Structure a) Evidence of local arrangements to ensure that people with a clinical diagnosis of FH are referred for specialist assessment. Data source: Local data collection. b) Evidence of local arrangements to ensure that a protocol for referral for a specialist assessment is agreed between primary and secondary care. Data source: Local data collection. Process Proportion of people with a clinical diagnosis of FH referred for specialist assessment. Numerator – The number of people in the denominator referred for specialist assessment. Denominator – The number of people with a clinical diagnosis of FH. Data source: Local data collection. Outcome Ratio of observed to estimated numbers of people with FH, using an estimate based on the area's estimated prevalence of FH (based on 1 in 500) and population size. Data
